Export 2751 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
B. C. Toy, Agron, E., Nigam, D. L., Chew, E. Y., and Wong, W. T., “Longitudinal Analysis of Retinal Hemangioblastomatosis and Visual Function in Ocular von Hippel Lindau Disease”, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2011.
B. C. Toy, Agrón, E., Nigam, D., Chew, E. Y., and Wong, W. T., “Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.”, Ophthalmology, vol. 119, no. 12, pp. 2622-30, 2012.
B. Toy, Agron, E., Nigam, D., Chew, E., and Wong, W. T., “Longitudinal Analysis of Retinal Hemangioblastomatosis and Visual Function in Ocular Von Hippel-Lindau Disease”, Opthalmology, vol. 119, pp. 2622-2630, 2012.
B. Trachtenberg, Velazquez, D., Williams, A., McNiece, I., Fishman, J., Nguyen, K., Rouy, D., Altman, P., Schwarz, R., Mendizabal, A., Oskouei, B., Byrnes, J., Soto, V., Tracy, M., Zambrano, J., Heldman, A., and Hare, J., “Rationale and Design of the Transendocardial Injection of Autologous Human Cells (Bone Marrow or Mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) Trial [..]”, Am Heart J, vol. 161, pp. 487-493, 2011.
B. Trachtenberg, Velazquez, D. L., Williams, A. R., McNiece, I., Fishman, J., Nguyen, K., Rouy, D., Altman, P., Schwarz, R., Mendizabal, A., Oskouei, B., Byrnes, J., Soto, V., Tracy, M., Zambrano, J. Pablo, Heldman, A. W., and Hare, J. M., “Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind”, Am Heart J, vol. 161, no. 3, pp. 487-93, 2011.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., “A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.”, J Infect Dis, vol. 210, no. 11, pp. 1763-71, 2014.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., “A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate-Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults”, J Infect Dis, vol. pii: jiu33, 2014.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., “Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults”, Vaccine, vol. 20, pp. 1099-1105, 2002.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O'Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., “Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.”, Vaccine, vol. 19, no. 13-14, pp. 1732-7, 2001.
J. J. Treanor, Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., Hay, C. M., Wolff, M. C., She, D., and Cox, M. J. C., “Dose-Related Safety and Immunogenicity of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults”, J Infec Dis, vol. 193, pp. 1223-1228, 2006.
J. J. Treanor, Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., C Hay, M., Wolff, M., She, D., and Cox, M. M. J., “Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.”, J Infect Dis, vol. 193, no. 9, pp. 1223-8, 2006.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., “Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.”, Vaccine, vol. 20, no. 7-8, pp. 1099-105, 2002.
J. J. Treanor, Campbell, J., Zangwill, K. M., Rowe, T., and Wolff, M. C., “Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine”, N Engl J Med, vol. 354, pp. 1343-1351, 2006.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O’Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., “Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans”, Vaccine, vol. 19, pp. 1732-1737, 2001.
J. J. Treanor, Campbell, J. D., Zangwill, K. M., Rowe, T., and Wolff, M., “Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.”, N Engl J Med, vol. 354, no. 13, pp. 1343-51, 2006.
J. V. Tricoli, Schoenfeldt, M., and Conley, B. A., “Detection of prostate cancer and predicting progression: current and future diagnostic markers.”, Clin Cancer Res, vol. 10, no. 12 Pt 1, pp. 3943-53, 2004.
J. V. Tricoli, Schoenfeldt, M., and Conley, B., “Detection of prostate cancer and predicting progression: current and future diagnostic markers”, Clinical Cancer Research, vol. 10, pp. 3943-3953, 2004.
E. L. Trimble, Schoenfeldt, M., and Cornelison, T. L., “Clinical trials referral resource. Current clinical trails in endometrial cancer.”, Oncology (Williston Park), vol. 17, no. 2, pp. 238-40, 244, 249, 2003.
E. Trimble, Valmonte, C. M., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials in epithelial ovarian cancer.”, Oncology (Williston Park), vol. 14, no. 5, pp. 678, 683-4, 687-8 passim, 2000.
E. L. Trimble and Schoenfeldt, M., “Clinical trials referral resource. Current treatment trials for epithelial ovarian cancer.”, Oncology (Williston Park), vol. 19, no. 7, pp. 897-8, 900, 905-6 passim, 2005.
E. Trimble and Schoenfeldt, M., “Clinical Trials Referral Resource. Current Treatment Trials for Epithelial Ovarian Cancer”, Oncology (Williston Park), vol. 19, pp. 897-898, 900, 905-906 passim, 2005.
E. L. Trimble, Schoenfeldt, M., Streicher, H., Gius, D., and Cornelison, T. L., “Clinical Trials Referral Resource. Clinical trials in cervical cancer.”, Oncology (Williston Park), vol. 17, no. 1, pp. 84-9, 2003.
E. L. Trimble and Schoenfeldt, M., “Clinical trials referral source. Current randomized phase III trials in gynecologic cancer.”, Oncology (Williston Park), vol. 18, no. 13, pp. 1642, 1645-6, 2004.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., “Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II)”, Oncology, vol. 15, pp. 601-3606-8 611, 2001.
E. L. Trimble, Schoenfeldt, M., Cornelison, T. L., Wright, J., Kolker, A., and Christian, M., “Clinical trials referral resource. Clinical trials in ovarian cancer, Part 2.”, Oncology (Williston Park), vol. 16, no. 12, pp. 1660-2, 1665-7, 2002.